I keep hearing the same story. Lantus and Toujeo (the "better Lantus") suck. Levemir and Tresiba (the "better Levemir") are decent.
That said—yes, a new basal can completely change what sorts of short-acting doses you need and that in itself isn't cause for alarm. But even once you work out your short-acting, some basals do legitimately make control harder than others.
In any case, why fix it if it ain't broke? Were you trying to get better results or was it just pushed on you as a "more modern" insulin? (Which Pharma are pushing onto medical professionals.)